Multiple Sclerosis
Literature Review
MRI May Reveal PML in Patients With Undetectable JCV
Patients with multiple sclerosis (MS) who are treated with natalizumab can have small progressive multifocal leukoencephalopathy (PML) lesions on...
Literature Review
Siponimod May Benefit Patients With Secondary Progressive MS
Among patients with secondary progressive multiple sclerosis (MS), siponimod appears to decrease the risk of disability progression, according to...
Conference Coverage
MRI Techniques Could Help Distinguish Between MS and Migraine
STOWE, VT—Some patients with migraine receive an inappropriate diagnosis of multiple sclerosis (MS). The two disorders share certain clinical and...
Conference Coverage
MS drugs in Medicare Part D: Higher tiers, less coverage, more prior authorizations
LOS ANGELES – The 2007-2016 analysis includes 11 drugs falling under Medicare Part D.
Guidelines
VIDEO: AAN MS guidelines aim to help clinicians weigh expanding drug choices
LOS ANGELES – A “dramatically different” landscape of treatment options allows better tailoring to patients, authors say.
Conference Coverage
Eating Fish May Be Associated With a Reduced Risk of MS
LOS ANGELES—Eating fish at least once per week or eating fish one to three times per month, in addition to taking daily fish oil...
From the Journals
Blood-brain barrier health may signal early loss of MS treatment response
A single dynamic contrast-enhanced MRI scan at 6 months was predictive in patients taking natalizumab or fingolimod.
Conference Coverage
Multiple sclerosis “top picks” from AAN 2018
Dr. Jonathan L. Carter from the Mayo Clinic Arizona shares his personal list of best MS abstracts at AAN 2018.
From the Journals
Rare, serious alemtuzumab adverse events emerge
New reports reveal rare adverse events in the treatment of relapsing-remitting multiple sclerosis using alemtuzumab.
Medical Education Library
Updates in MS: Highlights From the ECTRIMS and ACTRIMS Annual Meetings
This supplement to Neurology Reviews includes highlights from the Fall 2017 ECTRIMS meeting, plus highlights from the Winter 2018 ACTRIMS...
Video
Ari Green, MD
Dr. Green, Chief of the Division of Neuroinflammation and Glial Biology at the University of California, San Francisco, discusses the...